Brain Plasticity and Genetic Factors

REFERENCES

• Gresham G, Duncan P, Stason W, et al. Post-Stroke Rehabilitation. Rockville, MD: US Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research; 1995.
   Google Scholar
• Rathore S, Hinn A, Cooper L, Tyroler H, Rosamond W. Characterization of incident stroke signs and symptoms: findings from the atherosclerosis risk in communities study. Stroke. 2002;33(11):2718–2721.
   PubMed Web of Science ®Google Scholar
• Cramer S, Bastings E. Mapping clinically relevant plasticity after stroke. Neuropharmacology. 2000;39(5):842–851.
   PubMed Web of Science ®Google Scholar
• Frost S, Barbay S, Friel K, Plautz E, Nudo R. Reorganization of remote cortical regions after ischemic brain injury: a potential substrate for stroke recovery. I Neurophysiol. 2003;89(6):3205–3214.
   PubMed Web of Science ®Google Scholar
• Rossini PM, Calautti C, Pauri F, Baron JC. Post-stroke plastic reorganisation in the adult brain. Lancet Neurol. 2003;2(8):493–502.
   PubMed Web of Science ®Google Scholar
• Takahashi CD, Der Yeghiaian L, Cramer SC. Stroke recovery and its imaging. Neuroimaging Clin N Am. 2005;15(3):681–695.
   PubMed Web of Science ®Google Scholar
• Ward NS, Cohen LG. Mechanisms underlying recovery of motor function after stroke. Arch Neurol. 2004;61(12):1844–1848.
   PubMed Web of Science ®Google Scholar
• Cramer SC. Repairing the human brain after stroke: I. Mechanisms of spontaneous recovery. Ann Neurol. 2008;63(3):272–287.
   PubMed Web of Science ®Google Scholar
• Yozbatiran N, Cramer SC. Imaging motor recovery after stroke. NeuroRx. 2006;3(4):482–488.
   PubMedGoogle Scholar
• Ethell IM, Pasquale EB. Molecular mechanisms of dendritic spine development and remodeling. Prog Neurobiol. 2005;75(3):161–205.
   PubMed Web of Science ®Google Scholar
• Catterall WA, Dib-Hajj S, Meisler MH, Pietrobon D. Inherited neuronal ion channelopathies: new windows on complex neurological diseases. I Neurosci. 2008;28(46):11768–11777.
   Google Scholar
• Cull-Candy SG, Leszkiewicz DN. Role of distinct NMDA receptor subtypes at central synapses. Sci STKE. 2004;(255):re16.
   PubMedGoogle Scholar
• Kessels HW, Malinow R. Synaptic AMPA receptor plasticity and behavior. Neuron. 2009; 61(3):340–350.
   PubMed Web of Science ®Google Scholar
• Bliss TV, Collingridge GL. A synaptic model of memory: long-term potentiation inthehippocampus. Nature. 1993;361(6407):31–39.
   PubMed Web of Science ®Google Scholar
• Bailey CH, Kandel ER. Structural changes accompanying memory storage. Annu Rev Physiol. 1993;55:397–426.
   PubMed Web of Science ®Google Scholar
• Herring A, Ambree O, Tomm M, et al. Environ-mental enrichment enhances cellular plasticity in transgenic mice with Alzheimer-like pathology. Exp Neurol. 2009;216(1):184–192.
   PubMed Web of Science ®Google Scholar
• Volkmar F, Greenough W. Rearing complexity affects branching of dendrites in the visual cortex of the rat. Science. 1972;176(42):1145–1147.
   PubMedGoogle Scholar
• Chang FL, Greenough WT. Lateralized effects of monocular training on dendritic branching in adult split-brain rats. Brain Res. 1982;232(2):283–292.
   PubMed Web of Science ®Google Scholar
• Patel SN, Rose SP, Stewart MG. Training induced dendritic spine density changes are specifically related to memory formation processes in the chick, Gallus domesticus. Brain Res. 1988;463(1):168–173.
   Google Scholar
• Bailey CH, Chen M. Morphological basis of long-term habituation and sensitization in Aplysia. Science. 1983;220(4592):91–93.
   PubMed Web of Science ®Google Scholar
• Agranoff BW, Davis RE, Brink JJ. Memory fixation in the goldfish. Proc Natl Acad Sci USA. 1965;54(3): 788–793.
   PubMed Web of Science ®Google Scholar
• Bullock S, Csillag A, Rose SP. Synaptic vesicle proteins and acetylcholine levels in chick forebrain nuclei are altered by passive avoidance training. I Neurochem. 1987;49(3):812–820.
   PubMed Web of Science ®Google Scholar
• Kuhl D, Kennedy TE, Barzilai A, Kandel ER. Long-term sensitization training in Aplysia leads to an increase in the expression of BiP, the major protein chaperon of the ER. I Cell Biol. 1992;119(5): 1069–1076.
   Web of Science ®Google Scholar
• Pohle W, Ruthrich HL, Popov N, Matthies H. Fucose incorporation into rat hippocampus structures after acquisition of a brightness discrimination. A histoautoradiographic analysis. Acta Biol Med Ger. 1979;38(1):53–63.
   PubMedGoogle Scholar
• Cheeran B, TaleIli P, Mori F, et al. A common polymorphism in the brain-derived neurotrophic factor gene (BDNF) modulates human cortical plasticity and the response to rTMS. I Physiol. 2008;586(Pt 23):5717–5725.
   PubMed Web of Science ®Google Scholar
• Chen R. Interactions between inhibitory and excitatory circuits in the human motor cortex. Exp Brain Res. 2004;154(1):1–10.
   PubMed Web of Science ®Google Scholar
• Floel A, Breitenstein C, Hummel F, etal. Dopaminergic influences on formation of a motor memory. Ann Neurol. 2005;58(1):121–130.
   PubMed Web of Science ®Google Scholar
• Kleim JA, Chan S, Pringle E, et al. BDNF val66met polymorphism is associated with modified experience-dependent plasticity in human motor cortex. Nat Neurosci. 2006;9(6):735–737.
   PubMed Web of Science ®Google Scholar
• Reis J, Swayne OB, Vandermeeren Y, et al. Contri-bution of transcranial magnetic stimulation to the understanding of cortical mechanisms involved in motor control. I Physiol. 2008;586(2):325–351.
   PubMed Web of Science ®Google Scholar
• Kleim J, Kleim E, Cramer S. Systematic assess-ment of training-induced changes in corticospinal output to hand using frameless stereotaxic tran-scranial magnetic stimulation. Nature Protocols. 2007;2:1675–1684.
   PubMed Web of Science ®Google Scholar
• Floel A, Cohen LG. Translational studies in neurorehabilitation: from bench to bedside. Cogn Behav Neurol. 2006;19(1):1–10.
   PubMed Web of Science ®Google Scholar
• Merzenich MM, Jenkins WM. Reorganization of cortical representations of the hand following alterations of skin inputs induced by nerve injury, skin island transfers, and experience. I Hand Ther. 1993;6(2):89–104.
   PubMedGoogle Scholar
• Sanes J, Donoghue J. Plasticity and primary motor cortex. Annu Rev Neurosci. 2000;23:393–415.
   PubMed Web of Science ®Google Scholar
• Nudo RJ, Milliken GW, Jenkins WM, Merzenich MM. Use-dependent alterations of movement repre-sentations in primary motor cortex of adult squirrel monkeys. I Neurosci. 1996;16(2): 785–807.
   Google Scholar
• Kleim JA, Barbay S, Nudo RJ. Functional reorgan-ization of the rat motor cortex following motor skill learning. I Neurophysiol. 1998;80(6): 3321–3325.
   PubMed Web of Science ®Google Scholar
• Kleim JA, Hogg TM, VandenBerg PM, Cooper NR, Bruneau R, Remple M. Cortical synaptogenesis and motor map reorganization occur during late, but not early, phase of motor skill learning. I Neurosci. 2004;24(3):628–633.
   Web of Science ®Google Scholar
• Xerri C, Merzenich M, Peterson B, Jenkins W. Plasticity of primary somatosensory cortex paralleling sensorimotor skill recovery from stroke in adult monkeys. I Neurophysiol. 1998;79(4):2119–2148.
   PubMed Web of Science ®Google Scholar
• Nudo R, Milliken G, Jenkins W, Merzenich M. Use-dependent alterations of movement representations in primary motor cortex of adult squirrel monkeys. I Neurosci. 1996;16(2):785–807.
   Google Scholar
• Nudo RJ, Wise BM, SiFuentes F, Milliken GW. Neural substrates for the effects of rehabilitative training on motor recovery after ischemic infarct. Science. 1996;272(5269):1791–1794.
   PubMed Web of Science ®Google Scholar
• Butefisch CM, Kleiser R, Seitz RJ. Post-lesional cerebral reorganisation: evidence from functional neuroimaging and transcranial magnetic stimula-tion. I Physiol Paris. 2006;99(4-6):437–454.
   PubMed Web of Science ®Google Scholar
• Nudo R. Functional and structural plasticity in motor cortex: implications for stroke recovery. Phys Med Rehabil Clin N Am. 2003;14(1 Suppl): S57–76.
   Google Scholar
• Richards LG, Stewart KC, Woodbury ML, Senesac C, Cauraugh JH. Movement-dependent stroke recovery: a systematic review and meta-analysis of TMS and fMRI evidence. Neuropsychologia. 2008;46(1):3–11.
   PubMed Web of Science ®Google Scholar
• Rossini P, Dal Forno G. Neuronal post-stroke plasticity in the adult. Restor Neurol Neurosci. 2004;22(3-5):193–206.
   PubMed Web of Science ®Google Scholar
• Kleim JA, Jones TA. Principles of experience-dependent neural plasticity: implications for rehabilitation after brain damage. I Speech Lang Hear Res. 2008;51(1):5225–239.
   Web of Science ®Google Scholar
• Nudo RJ. Plasticity. NeuroRx. 2006;3(4):420–427.
   PubMedGoogle Scholar
• Stein DG. Sex differences in brain damage and recovery of function: experimental and clinical findings. Prog Brain Res. 2007;161:339–351.
   PubMed Web of Science ®Google Scholar
• Barde YA. Neurotrophins: a family of proteins supporting the survival of neurons. Prog Clin Biol Res. 1994;390:45–56.
   PubMedGoogle Scholar
• Lewin GR. Neurotrophins and the specification of neuronal phenotype. Philos Trans R Soc Lond B Biol Sci. 1996;351 (1338):405–411 .
   PubMed Web of Science ®Google Scholar
• Thoenen H. The changing scene of neurotrophic factors. Trends Neurosci. 1991;14(5):165–170.
   PubMed Web of Science ®Google Scholar
• Levine ES, Dreyfus CF, Black IB, Plummer MR. Brain-derived neurotrophic factor rapidly enhances synaptic transmission in hippocampal neurons via postsynaptic tyrosine kinase receptors. Proc Natl Acad Sci USA. 1995;92(17):8074–8077.
   PubMed Web of Science ®Google Scholar
• Lu B. BDNF and activity-dependent synaptic modulation. Learn Mem. 2003;10(2):86–98.
   PubMed Web of Science ®Google Scholar
• Lohof AM, lp NY, Poo MM. Potentiation of develop-ing neuromuscular synapses by the neurotrophins NT-3 and BDNF. Nature. 1993;363(6427):350–353.
   PubMed Web of Science ®Google Scholar
• Lessmann V. Neurotrophin-dependent modulation of glutamatergic synaptic transmission in the mammalian CNS. Gen Pharmacol. 1998; 31 (5):667–674.
   PubMedGoogle Scholar
• Hartmann M, Neumann R, Lessmann V. Synaptic secretion of BDNF after high-frequency stimulation of glutamatergic synapses. Embo J. 2001;20(21): 5887–5897.
   PubMed Web of Science ®Google Scholar
• Kafitz KW, Rose CR, Thoenen H, Konnerth A. Neurotrophin-evoked rapid excitation through TrkB receptors. Nature. 1999;401 (6756):918–921.
   PubMed Web of Science ®Google Scholar
• Carter AR, Chen C, Schwartz PM, Segal RA. Brain-derived neurotrophic factor modulates cerebellar plasticity and synaptic ultrastructure. I Neurosci. 2002;22(4):1316–1327.
   Google Scholar
• Kang H, Schuman EM. Long-lasting neurotrophin-induced enhancement of synaptic transmission in the adult hippocampus. Science. 1995; 267(5204):1658–1662.
   PubMed Web of Science ®Google Scholar
• Li YX, Zhang Y, Lester HA, Schuman EM, Davidson N. Enhancement of neurotransmitter release induced by brain-derived neurotrophic factor in cultured hippocampal neurons. I Neurosci. 1998;18(24): 10231–10240.
   PubMed Web of Science ®Google Scholar
• Messaoudi E, Bardsen K, Srebro B, Bramham CR. Acute intrahippocampal infusion of BDNF induces lasting potentiation of synaptic transmission in the rat dentate gyrus. I Neurophysiol. 1998;79(1): 496–499.
   PubMed Web of Science ®Google Scholar
• Winter J. Brain derived neurotrophic factor, but not nerve growth factor, regulates capsaicin sensitivity of rat vagal ganglion neurones. Neurosci Lett. 1998;241(1):21–24.
   PubMed Web of Science ®Google Scholar
• Desai NS, Rutherford LC, Turrigiano GG. BDNF regulates the intrinsic excitability of cortical neurons. Learn Mem. 1999;6(3):284–291.
   PubMed Web of Science ®Google Scholar
• Schinder AF, Berninger B, Poo M. Postsynaptic target specificity of neurotrophin-induced presynaptic potentiation. Neuron. 2000;25(1):151–163.
   PubMed Web of Science ®Google Scholar
• Lu B, Chow A. Neurotrophins and hippocampal synaptic transmission and plasticity. I Neurosci Res. 1999;58(1):76–87.
   PubMed Web of Science ®Google Scholar
• McAllister AK. Subplate neurons: a missing link among neurotrophins, activity, and ocular dominance plasticity? Proc Natl Acad Sci USA. 1999;96(24):13600–13602.
   PubMed Web of Science ®Google Scholar
• Altar CA, Fritsche M, Lindsay RM. Cell body infusions of brain-derived neurotrophic factor increase forebrain dopamine release and serotonin metabolism determined with in vivo microdialysis. Adv Pharmacol. 1998;42:915–921.
   PubMedGoogle Scholar
• Genoud C, Knott GW, Sakata K, Lu B, Welker E. Altered synapse formation in the adult soma-tosensory cortex of brain-derived neurotrophic factor heterozygote mice. I Neurosci. 2004;24(10): 2394–2400.
   PubMed Web of Science ®Google Scholar
• Linnarsson S, Bjorklund A, Ernfors P. Learning deficit in BDNF mutant mice. Eur I Neurosci. 1997;9(12):2581–2587.
   PubMed Web of Science ®Google Scholar
• Ma YL, Wang HL, Wu HC, Wei CL, Lee EH. Brain-derived neurotrophic factor antisense oligonucleotide impairs memory retention and inhibits long-term potentiation in rats. Neuroscience. 1998;82(4):957–967.
   PubMed Web of Science ®Google Scholar
• Minichiello L, Korte M, Wolfer D, et al. Essential role for TrkB receptors in hippocampus-mediated learning. Neuron. 1999;24(2):401–414.
   PubMed Web of Science ®Google Scholar
• Mizuno M, Yamada K, Olariu A, Nawa H, Nabeshima T. Involvement of brain-derived neurotrophic factor in spatial memory formation and maintenance in a radial arm maze test in rats. I Neurosci. 2000;20(18):7116–7121.
   PubMed Web of Science ®Google Scholar
• Gorski JA, Zeiler SR, Tamowski S, Jones KR. Brain-derived neurotrophic factor is required for the maintenance of cortical dendrites. I Neurosci. 2003;23(17):6856–6865.
   Google Scholar
• Vaynman S, Gomez-Pinilla F. License to run: exercise impacts functional plasticity in the intact and injured central nervous system by using neurotrophins. Neurorehabil Neural Repair. 2005;19(4):283–295.
   PubMed Web of Science ®Google Scholar
• Kleim JA, Jones TA, Schallert T. Motor enrichment and the induction of plasticity before or after brain injury. Neurochem Res. 2003;28(11):1757–1769.
   PubMed Web of Science ®Google Scholar
• VandenBerg PM, Bruneau RM, Thomas N, Kleim JA. BDNF is required for maintaining motor map integrity in adult cerebral cortex. Program No. 681.5. 2004 Neuroscience Meeting Planner. San Diego, CA: Society for Neuroscience, 2004. Online.
   Google Scholar
• Kesslak JP, So V, Choi J, Cotman CW, Gomez-Pinilla F. Learning upregulates brain-derived neurotrophic factor messenger ribonucleic acid: a mechanism to facilitate encoding and circuit maintenance? Behav Neurosci. 1998;112(4):1012–1019.
   PubMed Web of Science ®Google Scholar
• Gomez-Pinilla F, So V, Kesslak JP. Spatial learning induces neurotrophin receptor and synapsin I in the hippocampus. Brain Res. 2001;904(1):13–19.
   PubMed Web of Science ®Google Scholar
• Hall J, Thomas KL, Everitt BJ. Rapid and selective induction of BDNF expression in the hippocampus during contextual learning. Nat Neurosci. 2000; 3(6):533–535.
   PubMed Web of Science ®Google Scholar
• Rattiner LM, Davis M, French CT, Ressler KJ. Brain-derived neurotrophic factor and tyrosine kinase receptor B involvement in amygdala-dependent fear conditioning. J Neurosci. 2004;24(20):4796–4806.
   PubMed Web of Science ®Google Scholar
• Rocamora N, Welker E, Pascual M, Soriano E. Upregulation of BDNF mRNA expression in the barrel cortex of adult mice after sensory stimulation. I Neurosci. 1996; 16(14):4411–4419.
   Google Scholar
• Klintsova AY, Dickson E, Yoshida R, Greenough WT. Altered expression of BDNF and its high-affinity receptor TrkB in response to complex motor learning and moderate exercise. Brain Res. 2004;1028(1):92–104.
   PubMed Web of Science ®Google Scholar
• Ishibashi H, Hihara S, Takahashi M, Heike T, Yokota T, Iriki A. Tool-use learning induces BDNF expression in a selective portion of monkey anterior parietal cortex. Brain Res Mol Brain Res. 2002; 102(1-2):110–112.
   PubMedGoogle Scholar
• Ishibashi H, Hihara S, Takahashi M, Heike T, Yokota T, Iriki A. Tool-use learning selectively induces expres-sion of brain-derived neurotrophic factor, its recep-tor trkB, and neurotrophin 3 in the intraparietal multisensory cortex of monkeys. Brain Res Cogn Brain Res. 2002;14(1):3–9.
   PubMedGoogle Scholar
• Uchida K, Baba H, Maezawa Y, et al. Increased expression of neurotrophins and their receptors in the mechanically compressed spinal cord of the spinal hyperostotic mouse (twy/twy). Acta Neuropathol. 2003;106(1):29–36.
   PubMed Web of Science ®Google Scholar
• Ferrer I, Krupinski J, Goutan E, Marti E, Ambrosio S, Arenas E. Brain-derived neurotrophic factor reduces cortical cell death by ischemia after middle cerebral artery occlusion in the rat. Acta Neuropathol (Bed). 2001;101(3):229–238.
   PubMed Web of Science ®Google Scholar
• Laske C, Stransky E, Leyhe T, et al. Stage-dependent BDNF serum concentrations in Alzheimer's disease. I Neural Transm. 2006;113(9):1217–1224.
   PubMed Web of Science ®Google Scholar
• Matzilevich DA, Rail JM, Moore AN, Grill RJ, Dash PK. High-density microarray analysis of hippocampal gene expression following experimental brain injury. I Neurosci Res. 2002;67(5):646–663.
   Web of Science ®Google Scholar
• Henderson CE, Camu W, Mettling C, et al. Neurotrophins promote motor neuron survival and are present in embryonic limb bud. Nature. 1993;363(6426):266–270.
   PubMed Web of Science ®Google Scholar
• Sendtner M, Holtmann B, Kolbeck R, Thoenen H, Barde YA. Brain-derived neurotrophic factor prevents the death of motoneurons in newborn rats after nerve section. Nature. 1992;360(6406): 757–759.
   PubMed Web of Science ®Google Scholar
• Yan Q, Elliott IL, Matheson C, et al. Influences of neurotrophins on mammalian motoneurons in vivo. Neurobiol. 1993;24(12):1555–1577.
   Google Scholar
• Ikeda O, Murakami M, Ino H, et al. Acute up-regulation of brain-derived neurotrophic factor expression resulting from experimentally induced injury in the rat spinal cord. Acta Neuropathol. 2001;102(3):239–245.
   PubMed Web of Science ®Google Scholar
• Comelli M, Seren M, Guidolin D, et al. Photochemi-cal stroke and brain-derived neurotrophic factor (BDNF) mRNA expression. Neuroreport. 1992;3(6): 473–476.
   PubMed Web of Science ®Google Scholar
• Kurozumi K, Nakamura K, Tamiya T, et al. Mesenchymal stem cells that produce neurotrophic factors reduce ischemic damage in the rat middle cerebral artery occlusion model. Mol Ther. 2005;11 (1):96–104.
   PubMed Web of Science ®Google Scholar
• Miyake K, Yamamoto W, Tadokoro M, et al. Alterations in hippocampal GAP-43, BDNF, and L1 following sustained cerebral ischemia. Brain Res. 2002;935(1-2):24–31.
   PubMed Web of Science ®Google Scholar
• Yamashita K, Wiessner C, Lindholm D, Thoenen H, Hossmann K. Post-occlusion treatment with BDNF reduces infarct size in a model of permanent occlusion of the middle cerebral artery in rat. Metab Brain Dis. 1997;12(4):271–280.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Pardridge WM. Blood-brain barrier targeting of BDNF improves motor function in rats with middle cerebral artery occlusion. Brain Res. 2006;1111 (1):227–229.
   PubMedGoogle Scholar
• Zhao L, Risedal A, Wojcik A, Hejzlar J, Johansson B, Kokaia Z. Enriched environment influences brain-derived neurotrophic factor levels in rat forebrain after focal stroke. Neurosci Lett. 2001;305(3): 169–172.
   PubMed Web of Science ®Google Scholar
• Schabitz WR, Berger C, Kollmar R, et al. Effect of brain-derived neurotrophic factor treatment and forced arm use on functional motor recovery after small cortical ischemia. Stroke. 2004;35(4): 992–997.
   PubMed Web of Science ®Google Scholar
• Shimizu E, Hashimoto K, lyo M. Ethnic difference of the BDNF 196G/A (val66met) polymorphism frequencies: the possibility to explain ethnic mental traits. Am I Med Genet B Neuropsychiatr Genet. 2004;126(1):122–123.
   Web of Science ®Google Scholar
• Seidah NG, Benjannet S, Pareek S, Chretien M, Murphy RA. Cellular processing of the neurotrophin precursors of NT3 and BDNF by the mammalian proprotein convertases. FEBS Lett. 1996;379(3): 247–250.
   PubMed Web of Science ®Google Scholar
• Egan MF, Kojima M, Callicott JFI, et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell. 2003;112(2):257–269.
   PubMed Web of Science ®Google Scholar
• Chen ZY, Patel PD, Sant G, et al. Variant brain-derived neurotrophic factor (BDNF) (Met66) alters the intracellular trafficking and activity-dependent secretion of wild-type BDNF in neurosecretory cells and cortical neurons./ Neurosci. 2004;24(18): 4401–4411.
   PubMed Web of Science ®Google Scholar
• Ho BC, Miley P, O'Leary DS, Librant A, Andreasen NC, Wassink TH. Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Va166Met gene polymorphism in patients with schizophrenia and healthy volunteers. Arch Gen Psychiatry. 2006;63(7):731–740.
   PubMed Web of Science ®Google Scholar
• Pezawas L, Verchinski BA, Mattay VS, et al. The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology. J Neurosci. 2004;24(45):10099–10102.
   PubMed Web of Science ®Google Scholar
• Szeszko PR, Lipsky R, Mentschel C, et al. Brain-derived neurotrophic factor val66met polymorphism and volume of the hippocampal formation. Mo/ Psychiatry. 2005;10(7):631–636.
   PubMed Web of Science ®Google Scholar
• Bueller JA, Aftab M, Sen S, Gomez-Hassan D, Burmeister M, Zubieta JK. BDNF Va166Met allele is associated with reduced hippocampal volume in healthy subjects. Biol Psychiatry. 2006;59(9): 812–815.
   PubMed Web of Science ®Google Scholar
• Frodl T, Schule C, Schmitt G, et al. Association of the brain-derived neurotrophic factor Va166Met polymorphism with reduced hippocampal volumes in major depression. Arch Gen Psychiatry. 2007;64(4):410–416.
   PubMed Web of Science ®Google Scholar
• Nemoto K, Ohnishi T, Mori T, et al. The Va166Met polymorphism of the brain-derived neurotrophic factor gene affects age-related brain morphology. Neurosci Lett. 2006;397(1-2):25–29.
   PubMed Web of Science ®Google Scholar
• Huang EJ, Reichardt LF. Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci. 2001;24:677–736.
   PubMed Web of Science ®Google Scholar
• Lu B, Pang PT, Woo NH. The yin and yang of neurotrophin action. Nat Rev Neurosci. 2005;6(8):603–614.
   PubMed Web of Science ®Google Scholar
• Hariri AR, Goldberg TE, Mattay VS, et al. Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. I Neurosci. 2003;23(17):6690–6694.
   Google Scholar
• Goldberg TE, ludicello J, Russo C, et al. BDNF Va166Met polymorphism significantly affects d' in verbal recognition memory at short and long delays. Biol Psychol. 2008;77(1):20–24.
   PubMed Web of Science ®Google Scholar
• McHughen S, Kleim JA, Kleim ED, Procaccio V, Cramer SC. BDNF val66met polymorphism and short-term experience-dependent plasticity in the human brain [abstract]. Organization for Human Brain Mapping Annual Meeting; 2007; Chicago, Illinois.
   Google Scholar
• Laske C, Stransky E, Leyhe T, et al. Stage-dependent BDNF serum concentrations in Alzheimer's disease. Neural Transm. 2006;113(9):1217–1224.
   PubMed Web of Science ®Google Scholar
• Siironen I, Juvela S, Kanarek K, Vilkki J, Hernesniemi J, Lappalainen J. The Met allele of the BDNF Va166Met polymorphism predicts poor outcome among survivors of aneurysmal subarachnoid hemorrhage. Stroke. 2007;38(10):2858–2860.
   PubMed Web of Science ®Google Scholar
• Vilkki J, Lappalainen J, Juvela S, Kanarek K, Hernesniemi JA, Siironen J. Relationship of the met allele of the brain-derived neurotrophic factor Va166Met polymorphism to memory after aneurysmal subarachnoid hemorrhage. Neurosurgery. 2008;63(2):198–203; discussion 203.
   PubMed Web of Science ®Google Scholar
• Mahley RW, Rail SC Jr. Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet. 2000;1:507–537.
   PubMed Web of Science ®Google Scholar
• Cedazo-Minguez A. Apolipoprotein E and Alzheimer's disease: molecular mechanisms and therapeutic opportunities. I Cell Mol Med. 2007;11(6):1227–1238.
   PubMed Web of Science ®Google Scholar
• Eichner JE, Dunn ST, Perveen G, Thompson DM, Stewart KE, Stroehla BC. Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review. Am I Epidemiol. 2002;155(6):487–495.
   PubMed Web of Science ®Google Scholar
• Bersano A, Ballabio E, Bresolin N, Candelise L. Genetic polymorphisms for the study of multifactorial stroke. Hum Mutat. 2008;29(6): 776–795.
   PubMed Web of Science ®Google Scholar
• Nathan BP, Nisar R, Randall S, et al. Apolipoprotein E is upregulated in olfactory bulb glia following peripheral receptor lesion in mice. Exp Neurol. 2001;172(1):128–136.
   PubMed Web of Science ®Google Scholar
• Nwosu I, Gairhe S, Struble RG, Nathan BR Impact of apoE deficiency during synaptic remodeling in the mouse olfactory bulb. Neurosci Lett. 2008;441(3):282–285.
   PubMed Web of Science ®Google Scholar
• White F, Nicoll JA, Roses AD, Horsburgh K. Impaired neuronal plasticity in transgenic mice expressing human apolipoprotein E4 compared to E3 in a model of entorhinal cortex lesion. Neurobiol Dis. 2001;8(4):611–625.
   PubMed Web of Science ®Google Scholar
• Holtzman DM, Pitas RE, Kilbridge J, et al. Low density lipoprotein receptor-related protein mediates apolipoprotein E-dependent neurite outgrowth in a central nervous system-derived neuronal cell line. Proc Natl Acad Sci USA. 1995;92(21):9480–9484.
   PubMed Web of Science ®Google Scholar
• Arendt T, Schindler C, Bruckner MK, et al. Plastic neuronal remodeling is impaired in patients with Alzheimer's disease carrying apolipoprotein epsilon 4 allele. I Neurosci. 1997;17(2):516–529.
   Google Scholar
• Corder EH, Saunders AM, Strittmatter WI, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 1993;261(5123):921–923.
   PubMed Web of Science ®Google Scholar
• Hyman BT, Gomez-Isla T, Rebeck GW, et al. Epidemiological, clinical, and neuropathological study of apolipoprotein E genotype in Alzheimer's disease. Ann NY Acad Sci. 1996;802:1–5.
   PubMed Web of Science ®Google Scholar
• Caselli RJ, Graff-Radford NR, Reiman EM, et al. Preclinical memory decline in cognitively normal apolipoprotein E-epsilon4 homozygotes. Neurology. 1999;53(1):201–207.
   PubMed Web of Science ®Google Scholar
• De Blasi S, Montesanto A, Martino C, et al. APOE polymorphism affects episodic memory among non demented elderly subjects. Exp Gerontol. 2009;44(3):224–227.
   PubMed Web of Science ®Google Scholar
• Plassman BL, Welsh-Bohmer KA, Bigler ED, et al. Apolipoprotein E epsilon 4 allele and hippocampal volume in twins with normal cognition. Neurology. 1997;48(4):985–989.
   PubMed Web of Science ®Google Scholar
• Burggren AC,Zeineh MM, Ekstrom AD, etal. Reduced cortical thickness in hippocampal subregions among cognitively normal apolipoprotein E e4 carriers. Neuroimage. 2008;41 (4):1177–1183.
   PubMed Web of Science ®Google Scholar
• Mueller SG, Schuff N, Raptentsetsang S, Elman J, Weiner MW. Selective effect of Apo e4 on CA3 and dentate in normal aging and Alzheimer's disease using high resolution MRI at 4 T. Neuroimage. 2008;42(1 ):42–48.
   PubMed Web of Science ®Google Scholar
• Greenwood PM, Lambert C, Sunderland T, Parasuraman R. Effects of apolipoprotein E genotype on spatial attention, working memory, and their interaction in healthy, middle-aged adults: results from the National Institute of Mental Health's BIOCARD study. Neuropsychology. 2005;19(2):199–211.
   PubMed Web of Science ®Google Scholar
• Bondi MW, Salmon DP, Monsch AU, et al. Episodic memory changes are associated with the APOE-epsilon 4 allele in nondemented older adults. Neurology. 1995;45(12):2203–2206.
   PubMed Web of Science ®Google Scholar
• Parasuraman R, Greenwood PM, Sunderland T. The apolipoprotein E gene, attention, and brain function. Neuropsychology. 2002;16(2): 254–274.
   PubMed Web of Science ®Google Scholar
• Reiman EM, CaseIli RJ, Yun LS, et al. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipo-protein E. N Engl J Med. 1996;334(12):752–758.
   PubMed Web of Science ®Google Scholar
• Xu G, McLaren DG, Ries ML, et al. The influence of parental history of Alzheimer's disease and apolipoprotein E epsilon4 on the BOLD signal during recognition memory. Brain. 2009;132 (Pt 2):383–391.
   PubMedGoogle Scholar
• Teasdale GM, Nicoll JA, Murray G, Fiddes M. Association of apolipoprotein E polymorphism with outcome after head injury. Lancet. 1997;350(9084):1069–1071.
   PubMed Web of Science ®Google Scholar
• Zhou W, Xu D, Peng X, Zhang Q, Jia J, Crutcher KA. Meta-analysis of APOE4 allele and outcome after traumatic brain injury. J Neurotrauma. 2008;25(4):279–290.
   PubMed Web of Science ®Google Scholar
• Martinez-Gonzalez NA, Sudlow CL. Effects of apolipoprotein E genotype on outcome after ischaemic stroke, intracerebral haemorrhage and subarachnoid haemorrhage. I Neurol Neurosurg Psychiatry. 2006;77(12):1329–1335.
   PubMed Web of Science ®Google Scholar
• Waters RJ, Nicoll JA. Genetic influences on outcome following acute neurological insults. Curr Opin Crit Care. 2005;11(2):105–110.
   PubMed Web of Science ®Google Scholar
• Cramer SC, Warren M, Enney L, Sanaee N, Hancock S, Procaccio V. Polymorphisms in BDNF and ApoE relate to clinical outcome in the GAIN trials [abstract]. International Stroke Conference; 2009; San Diego. Stroke. 2009:40:e28.
   Google Scholar
• Matthews PM, Johansen-Berg H, Reddy H. Non-invasive mapping of brain functions and brain recovery: applying lessons from cognitive neuroscience to neurorehabilitation. Restor Neurol Neurosci. 2004;22(3-5):245–260.
   PubMed Web of Science ®Google Scholar
• Dobkin B. The Clinical Science of Neurologic Rehabilitation. New York: Oxford University Press; 2003.
   Google Scholar
• Krakauer JW. Motor learning: its relevance to stroke recovery and neurorehabilitation. Curr Opin Neurol. 2006;19(1):84–90.
   PubMed Web of Science ®Google Scholar
• Mattay VS, Goldberg TE, Fera F, et al. Catechol 0-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine. Proc Natl Acad Sci USA. 2003; 100(10):6186–6191.
   PubMed Web of Science ®Google Scholar
• Weinberger NM. Specific long-term memory traces in primary auditory cortex. Nat Rev Neurosci. 2004;5(4):279–290.
   PubMed Web of Science ®Google Scholar
• Stefan K, Wycislo M, Classen J. Modulation of associative human motor cortical plasticity by attention. J Neurophysiol. 2004;92(1):66–72.
   PubMed Web of Science ®Google Scholar
• Bobb AJ, Addington AM, Sidransky E, et al. Support for association between ADHD and two candidate genes: NET1 and DRD1. Am J Med Genet B Neuropsychiatr Genet. 2005;134(1):67–72.
   Google Scholar
• Shaw P, Gornick M, Lerch J, et al. Polymorphisms of the dopamine D4 receptor, clinical outcome, and cortical structure in attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 2007;64(8):921–931.
   PubMed Web of Science ®Google Scholar
• Faraone SV, Perlis RH, Doyle AE, et al. Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry. 2005;57(11):1313–1323.
   PubMed Web of Science ®Google Scholar
• Kirley A, Lowe N, Hawi Z, et al. Association of the 480 bp DAT1 allele with methylphenidate response in a sample of Irish children with ADHD. Am I Med Genet B Neuropsychiatr Genet. 2003;121B(1):50–54.
   PubMed Web of Science ®Google Scholar
• Cook EH Jr, Stein MA, Krasowski MD, et al. Association of attention-deficit disorder and the dopamine transporter gene. Am I Hum Genet. 1995;56(4):993–998.
   PubMed Web of Science ®Google Scholar
• Curran S, Mill J, Tahir E, et al. Association study of a dopamine transporter polymorphism and attention deficit hyperactivity disorder in UK and Turkish samples. Mo/ Psychiatry. 2001;6(4): 425–428.
   PubMed Web of Science ®Google Scholar
• Xu X, Mill J, Sun B, et al. Association study of promoter polymorphisms at the dopamine transporter gene in Attention Deficit Hyperactivity Disorder. BMC Psychiatry. 2009;9:3.
   PubMed Web of Science ®Google Scholar
• Kopeckova M, Paclt I, Goetz P. Polymorphisms and low plasma activity of dopamine-beta-hydroxylase in ADHD children. Neuro Endocrinol Lett. 2006;27(6):748–754.
   PubMed Web of Science ®Google Scholar
• Thapar A, O'Donovan M, Owen MJ. The genetics of attention deficit hyperactivity disorder. Hum Mol Genet. 2005; 14 Spec No. 2:R275–282.
   Google Scholar
• Brookes KJ, Hawi Z, Kirley A, Barry E, Gill M, Kent L. Association of the steroid sulfatase (STS) gene with attention deficit hyperactivity disorder. Am I Med Genet B Neuropsychiatr Genet. 2008;1476(8): 1531–1535.
   Google Scholar
• Bellgrove MA, Mattingley JB. Molecular genetics of attention. Ann NY Acad Sci. 2008;1129:200–212.
   PubMed Web of Science ®Google Scholar
• Greenwood PM, Sunderland T, Putnam K, Levy J, Parasuraman R. Scaling of visuospatial attention undergoes differential longitudinal change as a function of APOE genotype prior to old age: results from the NIMH BIOCARD study. Neuropsychology. 2005;19(6):830–840.
   PubMed Web of Science ®Google Scholar
• Takahashi CD, Der-Yeghiaian L, Le V, Motiwala RR, Cramer SC. Robot-based hand motor therapy after stroke. Brain. 2008;131(Pt 2):425–437.
   PubMed Web of Science ®Google Scholar
• Belmaker RH, Agam G. Major depressive disorder. N Engl I Med. 2008;358(1):55–68.
   PubMed Web of Science ®Google Scholar
• Hadidi N, Treat-Jacobson DJ, Lindquist R. Poststroke depression and functional outcome: a critical review of literature. Heart Lung. 2009;38(2):151–162.
   PubMed Web of Science ®Google Scholar
• Morris PL, Robinson RG, And rzejewski P, Samuels J, Price TR. Association of depression with 10-year poststroke mortality. Am I Psychiatry. 1993;150(1):124–129.
   PubMed Web of Science ®Google Scholar
• aanhet Rot M, Mathew SJ, Charney DS. Neurobiological mechanisms in major depressive disorder. Can Med Assoc J. 2009;180(3):305–313.
   Web of Science ®Google Scholar
• Hirschfeld RM. History and evolution of the monoamine hypothesis of depression. I Clin Psychiatry. 2000;61 Suppl 6:4–6.
   PubMed Web of Science ®Google Scholar
• Levinson DF. The genetics of depression: a review. Biol Psychiatry. 2006;60(2):84–92.
   PubMed Web of Science ®Google Scholar
• McMahon FJ, Buervenich S, Charney D, et al. Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment. Am I Hum Genet. 2006;78(5):804–814.
   PubMed Web of Science ®Google Scholar
• Martinowich K, Manji H, Lu B. New insights into BDNF function in depression and anxiety. Nat Neurosci. 2007;10(9):1089–1093.
   PubMed Web of Science ®Google Scholar
• Hwang JP, Tsai SJ, Hong CJ, Yang CH, Lirng JF, Yang YM. The Va166Met polymorphism of the brain-derived neurotrophic-factor gene is associated with geriatric depression. Neurobiol Aging. 2006;27(12):1834–1837.
   PubMed Web of Science ®Google Scholar
• Taylor WD, Zuchner S, McQuoid DR, Steffens DC, Speer MC, Krishnan KR. Allelic differences in the brain-derived neurotrophic factor Va166Met polymorphism in late-life depression. Am I Geriatr Psychiatry. 2007;15(10):850–857.
   PubMed Web of Science ®Google Scholar
• Tsai SJ, Cheng CY, Yu YW, Chen TJ, Hong Cl. Association study of a brain-derived neurotrophic-factor genetic polymorphism and major depressive disorders, symptomatology, and antidepressant response. Am I Med Genet B Neuropsychiatr Genet. 2003;123B(1):19–22.
   PubMed Web of Science ®Google Scholar
• Hong CJ, Huo SJ, Yen FC, Tung CL, Pan GM, Tsai SJ. Association study of a brain-derived neurotrophic-factor genetic polymorphism and mood disorders, age of onset and suicidal behavior. Neuropsychobiology. 2003;48(4):186–189.
   PubMed Web of Science ®Google Scholar
• Schumacher J, Jamra RA, Becker T, et al. Evidence for a relationship between genetic variants at the brain-derived neurotrophic factor (BDNF) locus and major depression. Bio/ Psychiatry. 2005;58(4):307–314.
   PubMed Web of Science ®Google Scholar
• Chen B, Dowlatshahi D, MacQueen GM, Wang JF, Young LT. Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Bio/ Psychiatry. 2001;50(4):260–265.
   Web of Science ®Google Scholar
• Bocchio-Chiavetto L, Miniussi C, Zanardini R, et al. 5-HTTLPR and BDNF Va166Met polymorphisms and response to rTMS treatment in drug resistant depression. Neurosci Lett. 2008;437(2):130–134.
   PubMed Web of Science ®Google Scholar
• Neeper SA, Gomez-Pinilla F, Choi J, Cotman CW. Physical activity increases mRNA for brain-derived neurotrophic factor and nerve growth factor in rat brain. Brain Res. 1996;726(1-2):49–56.
   PubMed Web of Science ®Google Scholar
• Gomez-Pinilla F, Ying Z, Roy RR, Molteni R, Edgerton VR. Voluntary exercise induces a BDNF-mediated mechanism that promotes neuroplasticity. I Neurophysiol. 2002;88(5): 2187–2195.
   PubMed Web of Science ®Google Scholar
• Vaynman S, Ying Z, Gomez-Pinilla F. Exercise induces BDNF and synapsin I to specific hippocampal subfields. I Neurosci Res. 2004;76(3):356–362.
   Web of Science ®Google Scholar
• Ploughman M, Granter-Button S, Chernenko G, Tucker BA, Mearow KM, Corbett D. Endurance exercise regimens induce differential effects on brain-derived neurotrophic factor, synapsin-I and insulin-like growth factor I after focal ischemia. Neuroscience. 2005;136(4):991–1001.
   PubMed Web of Science ®Google Scholar
• Rojas Vega S, Abel T, Lindschulten R, Hollmann W, Bloch W, Struder HK. Impact of exercise on neuroplasticity-related proteins in spinal cord injured humans. Neuroscience. 2008;153(4): 1064–1070.
   PubMed Web of Science ®Google Scholar
• Bryan A, Hutchison KE, Seals DR, Allen DL. A transdisciplinary model integrating genetic, physiological, and psychological correlates of volu n-tary exercise. Health Psychol. 2007;26(1):30–39.
   PubMed Web of Science ®Google Scholar
• Freedman JE, Hylek EM. Clopidogrel, genetics, and drug responsiveness. N Engl I Med. 2009;360(4):411–413.
   PubMed Web of Science ®Google Scholar
• Dam M, Tonin P, De Boni A, et al. Effects of fluoxetine and maprotiline on functional recov-ery in poststroke hemiplegic patients undergo-ing rehabilitation therapy. Stroke. 1996;27(7): 1211–1214.
   PubMed Web of Science ®Google Scholar
• Pariente J, Loubinoux I, Carel C, et al. Fluoxetine modulates motor performance and cerebral activation of patients recovering from stroke. Ann Neurol. 2001;50(6):718–729.
   PubMed Web of Science ®Google Scholar
• Zittel S, Weiller C, Liepert J. Citalopram improves dexterity in chronic stroke patients. Neurorehabil Neural Repair. 2008;22(3):311–314.
   PubMed Web of Science ®Google Scholar
• Zittel S, Weiller C, Liepert J. Reboxetine improves motor function in chronic stroke. A pilot study. Neurol. 2007;254(2):197–201.
   Web of Science ®Google Scholar
• Walker-Batson D, Smith P, Curtis S, Unwin H, Greenlee R. Amphetamine paired with physical therapy accelerates motor recovery after stroke. Further evidence. Stroke. 1995;26(12): 2254–2259.
   PubMed Web of Science ®Google Scholar
• Restemeyer C, Weiller C, Liepert J. No effect of a levodopa single dose on motor performance and motor excitability in chronic stroke. A double-blind placebo-controlled cross-over pilot study. Restor Neurol Neurosci. 2007;25(2):143–150.
   PubMed Web of Science ®Google Scholar
• Scheidtmann K, Fries W, Muller F, Koenig E. Effect of levodopa in combination with physiotherapy on functional motor recovery after stroke: a prospective, randomised, double-blind study. Lancet. 2001;358:787–790.
   PubMed Web of Science ®Google Scholar
• Grade C, Redford B, Chrostowski J, Toussaint L, Blackwell B. Methylphenidate in early post-stroke recovery: a double-blind, placebo-con-trolled study. Arch Phys Med Rehabil. 1998;79(9): 1047–1050.
   PubMed Web of Science ®Google Scholar
• Stein MA, Waldman ID, Sarampote CS, et al. Dopamine transporter genotype and meth-ylphenidate dose response in children with ADHD. Neuropsychopharmacology. 2005; 30(7):1374–1382.
   PubMed Web of Science ®Google Scholar
• Gilbert DL, Wang Z, Sallee FR, et al. Dopamine transporter genotype influences the physiological response to medication in ADHD. Brain. 2006;129(Pt 8):2038–2046.
   PubMedGoogle Scholar
• Peters EJ, Slager SL, McGrath PJ, Knowles JA, Hamilton SP. Investigation of serotonin-related genes in antidepressant response. Mo/ Psychiatry. 2004;9(9):879–889.
   Google Scholar
• Peters EJ, Slager SL, Jenkins GD, et al. Resequencing of serotonin-related genes and association of tagging SNPs to citalopram response. Pharmacogenet Genomics. 2009;19(1):1–10.
   PubMed Web of Science ®Google Scholar
• Smits KM, Smits LJ, Schouten JS, Stelma FF, Nelemans P, Prins MH. Influence of SERTPR and STin2 in the serotonin transporter gene on the effect of selective serotonin reuptake inhibitors in depression: a systematic review. Mol Psychiatry. 2004;9(5):433–441.
   PubMed Web of Science ®Google Scholar
• Hiratsuka M, Sasaki T, Mizugaki M. Genetic testing for pharmacogenetics and its clinical application in drug therapy. Clin Chim Acta. 2006;363(1-2): 177–186.
   PubMed Web of Science ®Google Scholar
• Ikeda T, Kurosawa M, Uchikawa C, Kitayama S, Nukina N. Modulation of monoamine transporter expression and function by repetitive transcranial magnetic stimulation. Biochem Biophys Res Commun. 2005;327(1):218–224.
   PubMed Web of Science ®Google Scholar
• Bath KG, Lee FS. Variant BDNF (Va166Met) impact on brain structure and function. Cogn Affect Behav Neurosci. 2006;6(1):79–85.
   PubMed Web of Science ®Google Scholar
• Jonsson E, Brene S, Zhang XR, et al. Schizophrenia and neurotrophin-3 alleles. Acta Psychiatr Scand. 1997;95(5):414–419.
   PubMed Web of Science ®Google Scholar
• Virgos C, Martorell L, Valero J, et al. Association study of schizophrenia with polymorphisms at six candidate genes. Schizophr Res. 2001;49 (1-2):65–71.
   PubMed Web of Science ®Google Scholar
• Chen Z, Simmons MS, Perry RT, Wiener HW, Harrell LE, Go RC. Genetic association of neurotrophic tyrosine kinase receptor type 2 (NTRK2) With Alzheimer's disease. Am I Med Genet B Neuropsychiatr Genet. 2008;147(3): 363–369.
   PubMedGoogle Scholar
• Bonifacio MJ, Palma PN, Almeida L, Soares-da-Silva P. Catechol-O-methyltransferase and its inhibitors in Parkinson's disease. CNS Drug Rev. 2007;13(3):352–379.
   PubMedGoogle Scholar
• Lotta T, Vidgren J, Tilgmann C, et al. Kinetics of human soluble and membrane-bound catechol 0-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry. 1995;34(13): 4202–4210.
   PubMed Web of Science ®Google Scholar
• Egan MF, Goldberg TE, Kolachana BS, et al. Effect of COMT Va1108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Nat/ Acad Sci USA. 2001;98(12):6917–6922.
   PubMed Web of Science ®Google Scholar
• Mannisto PT, Kaakkola S. Catechol-0-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors. Pharmacol Rev. 1999;51 (4):593–628.
   PubMed Web of Science ®Google Scholar
• Xu H, Kellendonk CB, Simpson EH, et al. DRD2 C957T polymorphism interacts with the COMT Va1158Met polymorphism in human working memory ability. Schizophr Res. 2007;90(1-3): 104–107.
   PubMed Web of Science ®Google Scholar
• Srivastava V, Varma PG, Prasad S, et al. Genetic susceptibility to tardive dyskinesia among schizophrenia subjects: IV. Role of dopaminergic pathway gene polymorphisms. Pharmacogenet Genomics. 2006;16(2):111–117.
   PubMed Web of Science ®Google Scholar
• Caldu X, Vendrell P, Bartres-Faz D, et al. Impact of the COMT Va1108/158 Met and DAT genotypes on prefrontal function in healthy subjects. Neuroimage. 2007;37(4):1437–1444.
   PubMed Web of Science ®Google Scholar
• Raz N, Rodrigue KM, Kennedy KM, Land S. Genetic and vascular modifiers of age-sensitive cognitive skills: effects of COMT, BDNF, ApoE, and hypertension. Neuropsychology. 2009;23(1): 105–116.
   PubMed Web of Science ®Google Scholar
• Mata I, Arranz MJ, Staddon S, Lopez-llundain JM, Tabares-Seisdedos R, Murray RM. The high-activity Val allele of the catechol-O-methyltransferase gene predicts greater cognitive deterioration in patients with psychosis. Psychiatr Genet. 2006;16(5): 213–216.
   PubMed Web of Science ®Google Scholar
• Galderisi S, Maj M, Kirkpatrick B, et al. Catechol-0-methyltransferase Va1158Met polymorphism in schizophrenia: associations with cognitive and motor impairment. Neuropsychobiology. 2005;52(2):83–89.
   PubMed Web of Science ®Google Scholar
• de Frias CM, Annerbrink K, Westberg L, Eriksson E, Adolfsson R, Nilsson LG. Catechol O-methyltransferase Va1158Met polymorphism is associated with cognitive performance in nondemented adults. I Cogn Neurosci. 2005; 17(7):1018–1025.
   PubMed Web of Science ®Google Scholar
• Starr IM, Fox H, Harris SE, Dearyll, Whalley U. COMT genotype and cognitive ability: a longitudinal aging study. Neurosci Lett. 2007;421(1):57–61.
   PubMed Web of Science ®Google Scholar
• Luria A. Restoration of Function after Brain Injury. New York: Macmillan; 1963.
   Google Scholar
• Burgard EC, Sarvey JM. Muscarinic receptor activation facilitates the induction of long-term potentiation (LTP) in the rat dentate gyrus. Neurosci Lett. 1990;116(1-2):34–39.
   PubMed Web of Science ®Google Scholar
• Hasselmo ME, Barkai E. Cholinergic modulation of activity-dependent synaptic plasticity in the piriform cortex and associative memory function in a network biophysical simulation. I Neurosci. 1995;15(10):6592–6604.
   Google Scholar
• Markram H, Segal M. Acetylcholine potentiates responses to N-methyl-D-aspartate in the rat hippocampus. Neurosci Lett. 1990;113(1):62–65.
   PubMed Web of Science ®Google Scholar
• Atri A, Sherman S, Norman K, et al. Blockade of central cholinergic receptors impairs new learning and increases proactive interference in a word paired-associate memory task. Behav Neurosci. 2004;118(1):223–236.
   PubMed Web of Science ®Google Scholar
• Beatty WW, Butters N, Janowsky DS. Patterns of memory failure after scopolamine treatment: implications for cholinergic hypotheses of dementia. Behav Neural Biol. 1986;45(2):196–211.
   PubMedGoogle Scholar
• Flicker C, Serby M, Ferris SH. Scopolamine effects on memory, language, visuospatial praxis and psychomotor speed. Psychopharmacology (Berl). 1990;100(2):243–250.
   PubMed Web of Science ®Google Scholar
• Rogers IL, Kesner RP. Cholinergic modulation of the hippocampus during encoding and retrieval. Neurobiol Learn Mem. 2003;80(3):332–342.
   PubMed Web of Science ®Google Scholar
• Elrod K, Buccafuscoll, Jackson WI. Nicotine enhances delayed matching-to-sample performance by primates. Life Sci. 1988;43(3):277–287.
   PubMed Web of Science ®Google Scholar
• Poltavski DV, Petros T. Effects of transdermal nicotine on prose memory and attention in smokers and nonsmokers. Physiol Behav. 2005;83(5):833–843.
   PubMed Web of Science ®Google Scholar
• Socci DJ, Sanberg PR, Arendash GW. Nicotine enhances Morris water maze performance of young and aged rats. Neurobiol Aging. 1995;16(5): 857–860.
   PubMed Web of Science ®Google Scholar
• Warburton DM, Rusted JM, Muller C. Patterns of facilitation of memory by nicotine. Behav Pharmacol. 1992;3(4):375–378.
   PubMed Web of Science ®Google Scholar
• Wesnes K, Warburton DM. Effects of scopolamine and nicotine on human rapid information processing performance. Psychopharmacology (Berl). 1984;82(3):147–150.
   PubMed Web of Science ®Google Scholar
• Giocomo LM, HasseImo ME. Neuromodulation by glutamate and acetylcholine can change circuit dynamics by regulating the relative influence of afferent input and excitatory feedback. Mo/ Neurobiol. 2007;36(2):184–200.
   PubMed Web of Science ®Google Scholar
• Scacchi R, Gambina G, Moretto G, Corbo RM. Variability of AChE, BChE, and ChAT genes in the late-onset form of Alzheimer's disease and relationships with response to treatment with Donepezil and Rivastigmine. Am I Med Genet B Neuropsychiatr Genet. 2009;150B(4):502–507.
   PubMed Web of Science ®Google Scholar
• Steinlein OK, Bertrand D. Neuronal nicotinic acetylcholine receptors: from the genetic analysis to neurological diseases. Biochem Pharmacol. 2008;76(10):1175–1183.
   PubMed Web of Science ®Google Scholar
• Stitzel JA. Naturally occurring genetic variability in the nicotinic acetylcholine receptor alpha4 and alpha7 subunit genes and phenotypic diversity in humans and mice. Front Biosci. 2008;13:477–491.
   PubMed Web of Science ®Google Scholar
• Edwards MJ, Huang YZ, Mir P, Rothwell JC, Bhatia KR Abnormalities in motor cortical plasticity differentiate manifesting and nonmanifesting DYT1 carriers. Mov Disord. 2006;21(12):2181–2186.
   PubMed Web of Science ®Google Scholar
• Hegde AN. Ubiquitin-proteasome-mediated local protein degradation and synaptic plasticity. Prog Neurobiol. 2004;73(5):311–357.
   PubMed Web of Science ®Google Scholar
• Wood MA, Kaplan MP, Brensinger CM, Guo W, Abel T. Ubiquitin C-terminal hydrolase L3 (Uch13) is involved in working memory. Hippocampus. 2005;15(5):610–621.
   PubMed Web of Science ®Google Scholar
• Liu Y, Fallon L, Lashuel HA, Liu Z, Lansbury PT, Jr. The UCH-L1 gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and Parkinson's disease susceptibility. Cell. 2002;111(2):209–218.
   PubMed Web of Science ®Google Scholar
• Meigs JB, Shrader P, Sullivan LM, et al. Genotype score in addition to common risk factors for prediction of type 2 diabetes. N Engl I Med. 2008;359(21):2208–2219.
   PubMed Web of Science ®Google Scholar
• Pharoah PD, Antoniou AC, Easton DF, Ponder BA. Polygenes, risk prediction, and targeted prevention of breast cancer. N Engl I Med. 2008;358(26): 2796–2803.
   PubMed Web of Science ®Google Scholar
• Zheng SL, Sun J, Wiklund F, et al. Cumulative association of five genetic variants with prostate cancer. N Engll Med. 2008;358(9):910–919.
   PubMed Web of Science ®Google Scholar